Income Statement
VSEE HEALTH, INC.
VSEE
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
14.62 | 10.42 | - | - |
|
Cost of Revenue
|
7.26 | 3.24 | - | - |
|
Gross Profit
|
7.36 | 7.18 | - | - |
|
Operating Expenses
|
16.94 | 69.33 | 2.59 | 3.59 |
|
Research & Development
|
- | - | - | - |
|
Selling, General & Administrative
|
10.04 | 6.55 | - | - |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-9.58 | -62.15 | -2.59 | -3.59 |
|
Non-Operating Income
|
-5.06 | 2.81 | -1.82 | 0.54 |
|
Interest Income
|
- | - | 0.36 | 0.92 |
|
Interest Expense
|
1.20 | 0.19 | 0.43 | 0.13 |
|
Other Non-Op Income / Expense
|
0.05 | 0.00 | - | - |
|
Income Before Tax
|
-14.64 | -59.34 | -4.41 | -3.06 |
|
Income Tax Expense
|
0.07 | -1.64 | 0.00 | 0.19 |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
-14.71 | -57.70 | -4.41 | -3.24 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-7.00 | -60.83 | -2.59 | -3.59 |
|
Earnings Per Share (Basic)
|
-0.73 | -5.65 | -1.08 | -0.25 |
|
Diluted EPS
|
-0.73 | -5.65 | -1.08 | -0.25 |
|
Weighted Average Shares
|
20.14 | 10.21 | 4.10 | 12.74 |
|
Diluted Weighted Avg Shares
|
20.14 | 10.21 | 4.10 | 12.74 |
|
Comprehensive Income
|
- | - | - | - |